GENE ONLINE|News &
Opinion
Blog

Phase 3 Trial
Bavarian Nordic Closes on Valneva in Chikungunya Vaccine Race
2023-08-14
Vistagen’s Positive Phase 3 Results for Social Anxiety Treatment
2023-08-10
Novartis’ CDK4/6 Inhibitor Meets Phase 3 Endpoints In Breast Cancer
2023-03-28
AstraZeneca’s Treatment for Rare Throat Disease, Eosinophilic esophagitis, Fails Primary Endpoint
2022-10-25
Merck’s Phase 2 HIV Treatment Study Resumes with Phase 3 Program Announcement
2022-09-20
Study for Janssen Pharmaceuticals’ Severe Plaque Psoriasis Treatment Provides Optimization Insight
2022-09-08
Belite Bio Clears Biopharma IPO Drought, with HilleVax and Tenon Medical Close Behind
2022-05-03
BioXcel Gets FDA Nod for First Oral Sublingual Film for Schizophrenia Treatment
2022-04-08
GSK’s Benlysta Bags Approval for Lupus Nephritis Treatment in China
2022-02-14
Applied Therapeutics’ Galactosemia Program Stumbles Again after FDA Requests for More Data
2022-01-04
Eli Lilly and Boehringer Ingelheim’s Jardiance Shows Encouraging Phase 3 HFpEF Data
2021-07-07
FDA Rejection of Type 1 Diabetes Drug Impacts Provention Bio’s Stocks
2021-07-07
AbbVie’s JAK1 Inhibitor Aces Ulcerative Colitis Trial, Prospers Amid Tough Regulatory Climate
2021-07-02
Novavax to Seek Regulatory Approval After COVID-19 Vaccine Displays 90% Efficacy in US Trial
2021-06-15
Samsung Biologics Renews Manufacturing Deal to Expand Production of TG Therapeutics’ Cancer Drug
2021-04-27
1 2 3 6
LATEST
Accelerated Bio and Pluristyx Generate Clinical-Grade Induced Pluripotent Stem Cells from Reprogrammed Human Trophoblast Stem Cells
2024-07-12
Novo Nordisk and PT Bio Farma Agree to Enhance Insulin Production for Diabetes Patients in Indonesia
2024-07-12
Alzheimer’s Drug LEQEMBI Approved for Treatment in Hong Kong
2024-07-12
Foreseen Biotech Strikes $1.03B Deal with Ipsen for First-in-Class ADC
2024-07-12
Synthetic Biology’s Innovator Dr. John Cumbers – Addressing Inefficiencies in Biopharma and Economic Sustainability
2024-07-11
Delivering Affordable Biologic Medicines Worldwide: An Interview with Tanvex Chairman and CEO, Henry Chen
2024-07-11
Roche Secures CE Mark for AI-Powered Glucose Monitoring Solution, Enhancing Diabetes Care with Predictive Insights
2024-07-11
EVENT
Scroll to Top